The U.S. Food and Drug Administration has updated the boxed warning tumor necrosis factor-alpha blockers to include the risk of infection from Legionella and Listeria. Read more.
On Dec. 31, 2012, the U.S. Food and Drug Administration (FDA) approved Fulyzaq (crofelemer) to relieve symptoms of diarrhea in HIV/AIDS patients taking antiretroviral therapy; it is the…
The U.S. Food and Drug Administration has approved Benlysta (belimumab) for treatment of lupus. The FDA last approved a drug for lupus in 1955. Read more at http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm246489.htm.
On June 13, the U.S. Food and Drug Administration (FDA) a new use for Lymphoseek (technetium 99m tilmanocept) Injection, a radioactive diagnostic imaging agent used to help determine…
On July 16, the U.S. Food and Drug Administration (FDA) approved Ruconest, the first recombinant C1-Esterase Inhibitor product for the treatment of acute attacks in adult and adolescent…
On Nov. 6, the U.S. Food and Drug Administration (FDA) approved Xeljanz (tofacitinib) to treat adults with moderately to severely active rheumatoid arthritis who have had an inadequate…
On Feb. 7, the U.S. Food and Drug Administration announced that drug interactions between the hepatitis C virus protease inhibitor Victrelis (boceprevir) and certain ritonavir-boosted human immunodeficiency virus…
Many patients with HIV/AIDS are doing well on highly active antiretroviral therapy (HAART). Yet HAART can increase cardiovascular risks by reducing high-density lipoprotein levels, raising triglyceride levels, and…
Health care professionals are at high risk for exposure to vaccine-preventable diseases and infections. Safeguard yourself, your patients, and your family members. Make sure you and your patients…
A study presented at the American Society of Clinical Oncology June meeting found that removing additional axillary lymph nodes to look for breast cancer in women with limited…
Researchers have developed a new intravaginal ring for the sustained 90-day co-delivery of tenofovir and levonorgestrel, an anti-human immunodeficiency virus (HIV) drug and a contraceptive. Tenofovir is the…
An advisory panel has recommended the U.S. Food and Drug Administration approve Benlysta; it would be the first new drug approved to treat Lupus in over 50 years.…
The U.S. Food and Drug Administration announced that new safety information has been added to the label for the HIV antiviral drug Invirase (saquinavir). The warning describes potentially…
Good news for younger women taking estrogen Estrogen therapy may have cardioprotective effects for women who start taking it in their 50s. A study from the Women’s Health…
CDC recommends HIV screening for everyone New recommendations from the Centers for Disease Control and Prevention (CDC) call for routine human immunodeficiency virus (HIV) screening for all patients…
American Diabetes Association releases food guidelines for specific medical categories “When you’re talking about diabetes, there is no ‘one size fits all’ diet,” said Ann Albright, PhD, RD,…
People older than age 50 account for at least 10% of HIV/AIDS cases in this country. Yet myths about older adults' behavior can blind us to the possibility…
Infection Control and Epidemiology has published “Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis.” Access…
The U.S. Food and Drug Administration has updated the boxed warning tumor necrosis factor-alpha blockers to include the risk of infection from Legionella and…
On Dec. 31, 2012, the U.S. Food and Drug Administration (FDA) approved Fulyzaq (crofelemer) to relieve symptoms of diarrhea in HIV/AIDS patients taking antiretroviral…
On June 13, the U.S. Food and Drug Administration (FDA) a new use for Lymphoseek (technetium 99m tilmanocept) Injection, a radioactive diagnostic imaging agent…
On July 16, the U.S. Food and Drug Administration (FDA) approved Ruconest, the first recombinant C1-Esterase Inhibitor product for the treatment of acute attacks…
On Nov. 6, the U.S. Food and Drug Administration (FDA) approved Xeljanz (tofacitinib) to treat adults with moderately to severely active rheumatoid arthritis who…
On Feb. 7, the U.S. Food and Drug Administration announced that drug interactions between the hepatitis C virus protease inhibitor Victrelis (boceprevir) and certain…
Many patients with HIV/AIDS are doing well on highly active antiretroviral therapy (HAART). Yet HAART can increase cardiovascular risks by reducing high-density lipoprotein levels,…
Health care professionals are at high risk for exposure to vaccine-preventable diseases and infections. Safeguard yourself, your patients, and your family members. Make sure…
A study presented at the American Society of Clinical Oncology June meeting found that removing additional axillary lymph nodes to look for breast cancer…
Researchers have developed a new intravaginal ring for the sustained 90-day co-delivery of tenofovir and levonorgestrel, an anti-human immunodeficiency virus (HIV) drug and a…
The U.S. Food and Drug Administration announced that new safety information has been added to the label for the HIV antiviral drug Invirase (saquinavir).…
CDC recommends HIV screening for everyone New recommendations from the Centers for Disease Control and Prevention (CDC) call for routine human immunodeficiency virus (HIV)…
American Diabetes Association releases food guidelines for specific medical categories “When you’re talking about diabetes, there is no ‘one size fits all’ diet,” said…
Infection Control and Epidemiology has published “Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations…
Reader Survey
Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.